Vergoeding 2019-2023 voor ATC-subgroep L01XX : Overige oncolytica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L01XX01 Amsacrine | 77.603 | 100.458 | 80.215 | 60.335 | 44.744 |
| L01XX02 Asparaginase | 999.579 | 1.060.732 | 1.228.456 | 1.631.879 | 816.418 |
| L01XX05 Hydroxycarbamide | 1.330.602 | 1.481.081 | 1.431.529 | 1.036.501 | 916.588 |
| L01XX11 Estramustine | 1.951 | 1.949 | 1.601 | 2.297 | 626 |
| L01XX23 Mitotaan | 463.259 | 467.432 | 351.419 | 428.932 | 425.920 |
| L01XX24 Pegaspargase | 2.416.527 | 1.784.906 | 1.326.677 | 1.140.387 | 1.034.558 |
| L01XX27 Arseentrioxide | 1.669.537 | 1.841.921 | 1.993.999 | 1.284.533 | 1.741.576 |
| L01XX35 Anagrelide | 925.865 | 641.578 | 486.418 | 295.156 | 254.024 |
| L01XX41 Eribuline | 1.463.001 | 1.394.237 | 1.148.292 | 1.333.760 | 1.176.231 |
| L01XX52 Venetoclax | 1.806.703 | 5.970.581 | 10.197.899 | 13.666.115 | 16.667.399 |
| L01XX62 Ivosidenib | . | . | . | . | 7.521 |
| Totaal | 11.154.627 | 14.744.873 | 18.246.505 | 20.879.895 | 23.085.605 |